Salvato in:
Dettagli Bibliografici
Autori principali: Lennart F. V. Spickschen, Svenja Kerpa, Tetiana Titko, Roland Thünauer, John M. Van Wazer, Amanda Fears, Amy Cao, Matthew D. Silva, Daniel L. J. Thorek, Elke Oetjen, Wolfgang Maison
Natura: Artículo Open Access
Pubblicazione: Wiley 2026
Soggetti:
Accesso online:https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.70320
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Sommario:
  • Phosphinate or Urea? Synthesis and Biological Evaluation of Prostate Specific Membrane Antigen‐Targeted Fluorophores With Different Zinc‐Binding Motif Lennart F. V. Spickschen Svenja Kerpa Tetiana Titko Roland Thünauer John M. Van Wazer Amanda Fears Amy Cao Matthew D. Silva Daniel L. J. Thorek Elke Oetjen Wolfgang Maison ChemMedChem Most prostate specific membrane antigen (PSMA)‐targeted drugs contain a urea‐based targeting vector, although high PSMA‐binding affinities have also been realized with other zinc‐binding motifs. This study describes the synthesis and evaluation of a hybrid compound containing a phosphinate motif (GPI) and a linker derived from an established urea‐based PSMA ligand (PSMA‐617). Fluorescent conjugates differing in their zinc‐binding motif only were synthesized and evaluated in vitro and in vivo. The phosphinate hybrid Cy5‐GPI617 ( 9 ) is more polar and has reduced binding affinity to human serum albumin (HSA) compared to its urea analog Cy5‐617 ( 10 ). At the same time, Cy5‐GPI617 ( 9 ) has an almost identical PSMA binding affinity (low nM) and leads to high, PSMA‐specific cellular uptake. In vivo, the phosphinate hybrid 9 showed reduced retention in nontumor tissues along with only moderately decreased tumor uptake compared to the urea analog 10 . These findings demonstrate that the previously performance‐limiting phosphate competition of GPI can be overcome by molecular engineering and highlight the potential of phosphinate‐based scaffolds for PSMA targeting. 10.1002/cmdc.70320 http://creativecommons.org/licenses/by/4.0/